A third dose of the Pfizer/BioNTech COVID-19 vaccine can "strongly" boost protection against the delta variant -- beyond the protection afforded by the standard two doses, suggests new data released ...

Pfizer and BioNTech said Monday they have submitted initial data to the US Food and Drug Administration to support the use of a booster dose of Covid-19 vaccine. Pfizer and BioNTech said Monday they ...

WASHINGTON - The U.S. Food and Drug Administration has authorized Pfizer’s COVID-19 vaccine booster for 12- to 15-year-olds. The expanded approval is an important step in clearing the extra shots for ...

Pfizer and Moderna asked the FDA last week to authorize another booster dose. As soon as Tuesday, the U.S. Food and Drug Administration could authorize COVID-19 booster shots for Americans over 50 ...

The group will discus and vote on whether to recommend Pfizer booster shots. The Food and Drug Administration's independent advisory committee will convene in open session Friday to review the latest ...

PHILADELPHIA (WPVI) -- The US Food and Drug Administration has granted emergency use authorization for a booster dose of Pfizer/BioNTech's COVID-19 vaccine for children ages 5 to 11 at least five ...

Pfizer is about to seek U.S. authorization for a third dose of its COVID-19 vaccine, saying Thursday that another shot within 12 months could dramatically boost immunity and maybe help ward off the ...

The Food and Drug Administration has issued approval for a booster shot of Pfizer's COVID-19 vaccine for children as young as 12. The Pfizer vaccine is the first booster shot to receive emergency ...

NEW YORK, N.Y. — Pfizer and BioNTech announced Tuesday that they’ve made a request for the Food and Drug Administration (FDA) to authorize their COVID-19 booster shot for all adults. Specifically, the ...

NEW YORK - Pfizer on Wednesday shared data about a third dose of its COVID-19 vaccine that suggests it "strongly" boosts protection against the more contagious delta variant of the coronavirus, which ...